NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement
生物瓣膜主动脉瓣置换术后前三个月内，新型口服抗凝药（NOAC）与华法林治疗房颤的疗效比较
期刊:
影响因子:
doi:10.5603/CJ.a2021.0158
Piepiorka-Broniecka, Marta; Michalski, Tomasz A; Figatowski, Tomasz; Wojtowicz, Andrzej; Jurowiecki, Jaroslaw; Stanska, Aleksandra; Rogowski, Jan; Jaguszewski, Milosz J
